SEC Comment Letter for AGENUS INC (AGEN) (CIK 0001098972) (AGEN) — Mar 18, 2010

AGENUS INC (AGEN) (CIK 0001098972)
Date: March 18, 2010 · CIK: 0001098972 · Accession: 0000000000-10-015086

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 000-29089

Date

March 18, 2010

Author

Jeffrey P. Riedler

Form

UPLOAD

Company

AGENUS INC (AGEN) (CIK 0001098972)

Letter

Mail Stop 4720 March 18, 2010 Garo H. Armen, Ph.D. President and Chief Executive Officer Antigenics Inc. 162 Fifth Avenue, Suite 900 New York, New York 10010 Re: Antigenics Inc. Preliminary Proxy Statement on Schedule 14A Filed March 15, 2010 Supplemental Response filed March 18, 2010 File No. 000-29089

Dear Dr. Armen: We have completed our review of your preliminary proxy statement on Schedule 14A and have no further comments at this time. Sincerely,

J e f f r e y P . R i e d l e r A s s i s t a n t D i r e c t o r

cc: Paul M. Kinsella Ropes & Gray LLP One International Place Boston, MA 02110-2624 Fax: 617-235-0822

Show Raw Text

Mail Stop 4720          March 18, 2010  Garo H. Armen, Ph.D.  President and Chief Executive Officer  Antigenics Inc. 162 Fifth Avenue, Suite 900  New York, New York 10010
Re: Antigenics Inc.
 Preliminary Proxy Statement on Schedule 14A
Filed March 15, 2010      Supplemental Response filed March 18, 2010
 File No. 000-29089

Dear Dr. Armen:
  We have completed our review of  your preliminary proxy statement on
Schedule 14A and have no further comments at this time.
Sincerely,

        J e f f r e y  P .  R i e d l e r          A s s i s t a n t  D i r e c t o r

 cc: Paul M. Kinsella
Ropes & Gray LLP  One International Place  Boston, MA 02110-2624
 Fax: 617-235-0822

SecProbe.io